Betta Pharmaceuticals Hits Day Low of CNY 65.32 Amid Price Pressure

Betta Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 3.91% as it reached an intraday low of CNY 65.32. This performance contrasts with the China Shanghai Composite, which saw a modest gain of 0.9% on the same day.
Over the past week, Betta Pharmaceuticals has shown a slight decrease of 0.39%, while its performance over the last month reflects a more significant decline of 4.86%. However, the company has demonstrated strong performance over the past year, achieving an impressive return of 80.57%, significantly outperforming the China Shanghai Composite's 25.1% gain.

Betta Pharmaceuticals maintains a market capitalization of CNY 27,699 million and exhibits a price-to-earnings ratio of 72.00. The company also boasts a return on equity of 6.92% and a dividend yield of 0.30%. Despite the recent downturn, Betta Pharmaceuticals has shown resilience in the long term, outperforming the broader market over various time frames, including a 67.11% increase over the past three years.